Abingdon Health Plc (LON:ABDX – Get Free Report) shares traded down 10.9% on Monday . The stock traded as low as GBX 6.21 ($0.08) and last traded at GBX 6.60 ($0.09). 568,962 shares were traded during mid-day trading, an increase of 362% from the average session volume of 123,217 shares. The stock had previously closed at GBX 7.40 ($0.10).
Abingdon Health Price Performance
The stock has a market cap of £12.59 million, a PE ratio of -15.80 and a beta of 0.13. The company has a debt-to-equity ratio of 46.64, a current ratio of 1.95 and a quick ratio of 1.96. The firm’s 50 day moving average price is GBX 7.50 and its two-hundred day moving average price is GBX 8.
Abingdon Health Company Profile
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.
See Also
- Five stocks we like better than Abingdon Health
- What is a Death Cross in Stocks?
- After Massive Post Earnings Fall, Does Hope Remain for MongoDB?
- How to Most Effectively Use the MarketBeat Earnings Screener
- Powell Warns of More Inflation—Here’s Where Smart Money Is Moving
- What is the Nasdaq? Complete Overview with History
- Is SoFi Stock Buyable at These Levels?
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
